Day: June 27, 2024
Trondheim, 27 June 2024: NORBIT ASA (“NORBIT” or the “Company“) announces that it has entered into a share purchase agreement to acquire 100 per cent of the equity interest in the technology company INNOMAR Technologie GmbH (“Innomar“), the market leader in the field of sub-bottom profilers in the maritime industry.
The acquisition of Innomar represents an attractive strategic fit with NORBIT as it contributes to broadening the product portfolio in the Oceans segment and diversifying its customer base.
About InnomarHeadquartered in Rostock, Germany, Innomar is the global market leader in the design, manufacturing, and distribution of parametric sub-bottom profilers. With nearly thirty years of experience in acoustic systems, signal processing, maritime electronics, and software, Innomar has developed...
Acuity Brands Reports Fiscal 2024 Third-Quarter Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Solid Execution Delivers Operating Margin Expansion, EPS Growth and Strong Operating Cash FlowDelivered Net Sales of $968M, a 3% Decline Compared to the Prior Year
Grew Operating Profit to $145M, up 1% Over the Prior Year; Adjusted Operating Profit of $167M, up 3% Over the Prior Year
Reported Diluted EPS of $3.62, up 10% Over the Prior Year; Adjusted Diluted EPS of $4.15, up 11% Over the Prior Year
Generated $445M in Year-to-Date Cash Flow from OperationsATLANTA, June 27, 2024 (GLOBE NEWSWIRE) — Acuity Brands, Inc. (NYSE: AYI) (the “Company”), a market-leading industrial technology company, announced net sales of $968.1 million in the third quarter of fiscal 2024 ended May 31, 2024, a decrease of $32.2 million, or 3.2 percent, compared to the prior year.
“In our fiscal 2024 third quarter we delivered solid results as we continued...
Medigene Presents Efficient 6-Day TCR-T Therapy Production Process with High Stemness
Written by Customer Service on . Posted in Public Companies.
Planegg/Martinsried, June 27, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today provides a detailed overview of its lead candidate MDG1015, a first-in-class 3rd generation T cell receptor engineered T cell (TCR-T) therapy, at the 7th Cell and Gene Therapy In-Depth Focus Summit from June 27-28, 2024, in Beijing, China. MDG1015 advances towards the clinic and targets the cancer-testisantigens (CTA) NY-ESO-1 / LAGE-1a (New York esophageal squamous cell carcinoma 1 / L Antigen Family Member-1a) and is armored and enhanced by the Company’s PD1-41BB costimulatory switch protein (CSP).
The presentation with the title “MDG1015: a 3rd Generation TCR-T Therapy Incorporating the PD1-41BB Costimulatory...
Form 8.3 – [MATTIOLI WOODS PLC] – 26 06 2024 – (CGWL)
Written by Customer Service on . Posted in Mergers And Acquisitions.
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION(a) Full name of discloser:
CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree
MATTIOLI WOODS PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
MATTIOLI WOODS PLC AS AN ASSOCIATE...
Form 8.3 – [LOK’N STORE GROUP PLC] – 26 06 2024 – (CGWL)
Written by Customer Service on . Posted in Mergers And Acquisitions.
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION(a) Full name of discloser:
CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree
LOK’N STORE GROUP PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
N/A(e) Date position...
Form 8.3 – [ KEYWORDS STUDIOS PLC] – 26 06 2024 – CGWL
Written by Customer Service on . Posted in Mergers And Acquisitions.
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION(a) Full name of discloser:
CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree
KEYWORDS STUDIOS PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
N/A(e) Date position...
Cost of new drug development is key concern for life science as focus shifts to repurposing
Written by Customer Service on . Posted in Public Companies.
LONDON, June 27, 2024 (GLOBE NEWSWIRE) — 63% of life science companies believe the high cost of new drug development is among the emerging themes that will have the greatest negative impact on the sector in the next 3-5 years, according to Global life science risk report 2024 published today by WTW (NASDAQ: WTW), a leading global advisory, broking, and solutions company. This is leading to an increased focus on finding novel use cases for existing drugs, named by 66% as having a positive impact, as firms seek to launch new products and expand their international footprint.
The 2nd life science global survey asked 400 senior decision makers belonging to pharmaceutical, biotech and other life science sector companies how they manage emerging risks and how they are preparing for the future.
The survey also revealed that regulation...
Freshworks Unveils New Data Center in UAE to Serve Customers Across Middle East and Africa
Written by Customer Service on . Posted in Public Companies.
DUBAI, UAE, June 27, 2024 (GLOBE NEWSWIRE) — Freshworks Inc. (NASDAQ: FRSH) today announced the launch of its new data center, powered by Amazon Web Services (AWS), in the UAE. This underscores Freshworks’ commitment to driving innovation across the Middle East and Africa (MEA) by making it easier for businesses to harness the full power of its modern, AI-powered customer and employee service solutions.
“We are thrilled to further strengthen our presence in MEA with the new data center in UAE,” said Abe Smith, Chief of Global Field Operations at Freshworks. “This investment demonstrates our dedication to supporting the growth and digital transformation of businesses in the region. With our data center, companies requiring regional data compliance within the UAE can depend on us for business software in Customer Service, IT, and...
Result of the auction of treasury bills on 27 June 2024
Written by Customer Service on . Posted in Public Companies.
Bids, sales, stop-rates and prices are presented in the table below: ISIN
Bid Mill. kr. (nominal)
Sale
Stop-rate (per cent)
Pro-rata
Price98 19583 DKT 03/09/24 III
100
100
3.260
100 %
99.423898 19666 DKT 02/12/24 IV
200
200
3.170
100 %
98.6621Total
300
300
The sale will settle 01 July 2024.
Scandinavian Tobacco Group A/S to acquire Mac Baren Tobacco Company A/S
Written by Customer Service on . Posted in Public Companies.
Company Announcement No. 35/2024
Copenhagen, 27 June 2024
Scandinavian Tobacco Group A/S to acquire Mac Baren Tobacco Company A/S
Scandinavian Tobacco Group has today agreed on the terms and conditions for the acquisition of all the shares of Mac Baren Tobacco Company A/S (“Mac Baren”) from Halberg A/S. On a debt and cash free basis (the enterprise value), the transaction is valued at DKK 535 million. The acquisition will be financed by cash at hand and debt. Closing of the transaction is expected shortly.
Mac Baren is a family-owned business founded in 1826 and is a leading global smoking tobacco company, which includes a strong portfolio of pipe tobacco brands such as Mac Baren, Amphora and Holger Danske as well as fine-cut tobacco brands like Amsterdamer, Choice and Opal. The company also produces and sells nicotine pouches with...